Rayo Pharma Private Limited, a active private limited company, was established on 23 October 2018 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33119GJ2018PTC104863. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Munir Mahendrakumar Shah (Director), Ashik Dhirubhai Sanghvi (Director), Jigneshkumar Arvindbhai Patel (Director). Past directors included Harish Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12, Navjivan (Kalyan) Co Op H Soc, Near Nagari Hospital, Ellis Bridge,, Ahmedabad, Gujarat, 380006.
U33119GJ2018PTC104863
104863
23 October 2018
₹1.00 M
₹1.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rayo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Munir Mahendrakumar Shah | Director | 23 Oct 2018 | Current |
| Ashik Dhirubhai Sanghvi | Director | 23 Oct 2018 | Current |
| Jigneshkumar Arvindbhai Patel | Director | 23 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rayo Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 192.2% increase. The company also saw a substantial improvement in profitability, with a 243.68% increase in profit. The company's net worth Soared by an impressive increase of 59.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rayo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rayo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rayo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rayo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rayo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Rayo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity Munir Mahendrakumar Shah was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 1 month . was completed.
The activity Ashik Dhirubhai Sanghvi was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 1 month . was completed.
Progress on Jigneshkumar Arvindbhai Patel was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
Progress on Rayo Pharma Private Limited was registered on 23 Oct 2018 with Roc Ahmedabad & aged 7 years 1 month as per MCA records. was documented.
The CIN of Rayo Pharma Private Limited is U33119GJ2018PTC104863.
Rayo Pharma Private Limited is headquartered at 12, Navjivan (Kalyan) Co Op H Soc, Near Nagari Hospital, Ellis Bridge,, Ahmedabad, Gujarat, 380006.
Rayo Pharma Private Limited was incorporated on 23 October 2018.
The current directors of Rayo Pharma Private Limited are
The primary industry of Rayo Pharma Private Limited is Trade.
Rayo Pharma Private Limited is unlisted.
The authorized capital of Rayo Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX